AvatarHindustan Timesflipped into EducationFlipboardIcon version of the Flipboard logo18 hours agoUniversity of Sheffield invites applications for MSc Pharmaceutical Engineering course for September 2024 intakehindustantimes.com - HT Education DeskStudents who study the course will learn new technologies used in pharmaceutical and biopharmaceutical processes, said a release issued by the …
AvatarThe Motley FoolAvatarAvatar1 day ago3 No-Brainer Stocks to Buy With $100 Right Nowverified_publisherThe Motley Fool - Sean WilliamsVolatility and short-term unpredictability are a few of the guarantees that Wall Street offers investors. Since the green flag waved in January 2020, …
Avatargeowarnerflipped into Our Democracy Thrives In The Light-Fight The Darkness/Support UkraineAvatarAvatar3 days agoDrugmakers' low U.S. taxes belie their high salesverified_publisherNPR - Sydney LupkinTax day is here. While Americans are scrambling to file last minute returns, things are somewhat more complicated for corporations. Corporations are supposed to pay a nominal tax rate of 21%. But in recent years, the biggest pharmaceutical companies had an average effective tax rate of less than …
FlipboardIcon version of the Flipboard logo1 day agoUniversities Are Profiting From Blocking Drug-Price Reformjacobin.com - Helen SantoroTeaming up with Big Pharma and Wall Street, universities are profiting by fighting government efforts to curtail soaring drug prices. A case in …
AvatarThe National Law Reviewflipped into Litigation, Trial, ADR, E-Discovery & Court NewsFlipboardIcon version of the Flipboard logo4 days agoA Win for the SEC on Shadow Trading. Now What?natlawreview.com - ArentFox Schiff LLPOn April 5, 2014, after an eight-day trial and a few hours of deliberation, a federal jury entered a verdict for the US Securities and Exchange …
Avatar8 Paths LLCflipped into P FinanceAvatarAvatar5 days agoThe Smartest Dividend Stocks to Buy With $400 Right Nowverified_publisherThe Motley Fool - Keith SpeightsWondering if investing in dividend stocks is a smart move? I'd point you to Warren Buffett. Buffett's Berkshire Hathaway portfolio is loaded with …
AvatarBioPharma Diveflipped into BiotechFlipboardIcon version of the Flipboard logo1 day agoCanaan hires Pfizer executive, reels in $100M for biotech investingbiopharmadive.com - Gwendolyn WuDive Brief:• Uwe Schoenbeck, a biotech veteran who most recently was chief scientific officer at Pfizer’s innovation division, has joined Canaan …
AvatarSTATflipped into STAT's HOMEPAGEAvatarAvatar2 days agoPharmalittle: We're reading about CVS and Humira biosimilars, Schumer's broken insulin promise, and moreSTAT - Ed SilvermanTop of the morning to you, and a fine one it is. Clear blue skies and cool breezes are currently enveloping the placid Pharmalot campus, where the …
AvatarBarron'sflipped into All Barron's StoriesAvatarAvatar4 days agoLarge Fund Bets Big on Groceries in the Face of Persistent InflationBarron's - Ed LinAlaska Permanent, the largest U.S. state wealth fund, just tripled investments in Walmart and Kroger, bought more Ford, and slashed a stake in Pfizer.
AvatarThe Motley FoolAvatarAvatar3 days agoWant $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.verified_publisherThe Motley Fool - Cory RenauerIf you're nervous about retiring without enough passive you have more than a few options. Buying rental properties is a popular one, but those …
AvatarForbesAvatarAvatar3 days agoThe 2024 Forbes Entrepreneurial CMO 50 List: By The NumbersForbes - Seth MatlinsWhen considering what can be divined from amongst the aggregate of the 50 marketing leaders recognized on this, the third annual Forbes Entrepreneurial CMO list, we must acknowledge that it reflects not just those recognized but also the pool of hundreds of nominees (this year seeing the greatest …
AvatarThe Wall Street Journal.flipped into Latest From the WSJAvatarAvatar5 days agoTwo Brothers, a Big Biotech Bet and an $8 Billion PayoutThe Wall Street Journal. - Peter RudegeairA two-decade bet on a biotechnology company turned into a roughly $8 billion windfall for investors in a New York hedge fund earlier this year. Baker Bros. Advisors, a hedge-fund firm run by brothers Julian Baker , had in 2003 invested in Seagen, a developer of next-generation cancer treatments. bought …